GSA Capital Partners’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
2021
Q1
$807K Buy